#Mpox Tongue Lesions

「2024 我和我的健康照護者」活動已經開始啟動， 邀請各位朋友們和大家分享在這一路上遇到的那些小故事， 無論是個案管理師、民間團體、社會工作者等等， 當你遇到了阻礙或困境，總是有人用不同的方法和角度在支持你。 活動網址：twmmph.org

【NHKニュース速報】 同性婚認めないのは憲法違反　札幌高裁　２審での違憲判断は全国で初めて(15:22) #nhk_news www3.nhk.or.jp/news/

用 #煙 #meth #ice #hifun 個案常見幻覺症狀 1. #聽幻覺（幻聽） 2. #視幻覺（看到現實中不存在的東西） 3. #被害妄想（常常跟聽幻覺結合在一起） 4. #被監視妄想 5. #關係妄想 6. #寄生蟲妄想 7. #蟻走感（覺得皮膚有蟲在爬）

A major takeaway coming out today's #DoxyPEP webinar 💥 Doxy-PEP should be a part of a comprehensive package of sexual health services. Check out this encompassing slide from Annie Luetkemeyer, courtesy of Stephanie Cohen.

Updated Infographic Alert! 🚨 With CAB for #PrEP approval in Malaysia, Nigeria, Peru, Zambia, and the European Medicines Agency, check out the new and improved infographic sharing a breakdown of allocation of non-commercial CAB for PrEP supply in #LMIC. avac.org/resource/infog…

Type 2 diabetes increasingly affects people with HIV as they get older. Our updated page provides information on the changes you can make to your lifestyle to reduce your risk; symptoms; diagnosis & monitoring; and treatment & management of type 2 diabetes aidsmap.com/about-hiv/diab…

Injectable HIV treatment underway in England and largely effective, but a couple of breakthrough cases raise concern dlvr.it/T6bc3v

Delighted to see Nymphia Wind 妮妃雅瘋 & fellow queens perform at the Presidential Office today. Nymphia, as the S16 winner of RuPaul's Drag Race, is now a queen for the world. We're all looking forward to you lighting up the stage with #Taiwanese pride at our pavilion at the Paris Olympics.

The SHARE Collaborative-led SHARE-LAI-net service evaluation of CAB+RPV implementation at 12 UK clinics is out in HIV Medicine ! The main points are here, but there is lots more at: doi.org/10.1111/hiv.13… Great to collaborate with such fantastic colleagues! ViiV Healthcare

(lilac colored spheres are HIV on an infected cell) I have seen some amazing new developments this year. Unconventional stuff, looking at HIV treatment, HIV reservoirs, and HIV prevention in new ways. Here is a remarkable study of re-engineered HIV administered in one dose. A

HIV治療薬ツルバダ、曝露前予防の承認取得 medical.nikkeibp.co.jp/leaf/mem/pub/h… #日経メディカル

Exciting news! Gilead Sciences has announced PURPOSE 2 trial interim results. 99.9% of cisgender men & gender-diverse people in the #lenacapavir group did not acquire #HIV. These results further strengthen the promise of lenacapavir for HIV prevention: gilead.com/news-and-press…

"Gilead Signs Royalty-Free Voluntary Licensing Agreements With Six Generic Manufacturers to Increase Access to #Lenacapavir for #HIV Prevention in High-Incidence, Resource-Limited Countries" businesswire.com/news/home/2024…

Speed, scale and equity are needed to translate injectable lenacapavir for #HIV #PrEP into impact -- and today's licensing announcement from Gilead Sciences is a step in the right direction -- but lots more to be done: heapnews.ng/gilead-signs-l…

Obesity is a major risk factor for knee osteoarthritis. Research evaluating whether the GLP-1 receptor agonist semaglutide is superior to placebo in reducing body weight and knee osteoarthritis pain is summarized in a new Quick Take video. youtu.be/oXKFttF1eDs

This study by Zachary Wagner and colleagues builds on emerging evidence by examining the relationship between adherence to #dolutegravir-based regimens and viral suppression in #Uganda. Read the full article here: bit.ly/40MyZWN